A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Class II Risk Alleles and Have an Inadequate Response to Methotrexate
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
University of Colorado Hospital
Principal Investigator
Christopher Striebich, MD, PhD
Study ID
Protocol Number: 21-3663
More information available at ClinicalTrials.gov: NCT04909801
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers